These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16768130)

  • 1. [Stroke and renin-angiotensin system].
    Tanahashi N
    Nihon Rinsho; 2006 Jun; 64(6):1191-9. PubMed ID: 16768130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications.
    Chrysant SG
    J Clin Hypertens (Greenwich); 2007 Jun; 9(6):454-9. PubMed ID: 17541331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the renin-angiotensin system and the prevention of stroke.
    Schrader J; Kulschewski A; Dendorfer A
    Am J Cardiovasc Drugs; 2007; 7(1):25-37. PubMed ID: 17355164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
    Pernomian L; Pernomian L; Baraldi Araújo Restini C
    Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of RAS modification for primary and secondary stroke prevention.
    Fintel DJ
    Postgrad Med; 2009 Jul; 121(4):115-22. PubMed ID: 19641277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
    Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
    Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should angiotensin II receptor blockers and statins be combined?
    Nickenig G
    Circulation; 2004 Aug; 110(8):1013-20. PubMed ID: 15326080
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebrovascular diseases and RAS].
    Matsumoto M
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1743-9. PubMed ID: 17037309
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atrial fibrillation and renin-angiotensin system].
    Yamashita T
    Nihon Rinsho; 2007 Mar; 65(3):569-74. PubMed ID: 17354577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renin-angiotensin system in atherosclerosis].
    Fukuda D; Sata M
    Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.
    Tsouli SG; Liberopoulos EN; Kiortsis DN; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):1-15. PubMed ID: 16703216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
    Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke.
    Sokol SI; Portnay EL; Curtis JP; Nelson MA; Hebert PR; Setaro JF; Foody JM
    Neurology; 2004 Jul; 63(2):208-13. PubMed ID: 15277610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
    Lambers Heerspink HJ
    Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of RAAS inhibition on stroke prevention].
    Tanahashi N
    Nihon Rinsho; 2012 Sep; 70(9):1582-7. PubMed ID: 23012807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE-Triggered Hypertension Incites Stroke: Genetic, Molecular, and Therapeutic Aspects.
    Vasudeva K; Balyan R; Munshi A
    Neuromolecular Med; 2020 Jun; 22(2):194-209. PubMed ID: 31802381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin receptor blockers and cerebral protection in stroke.
    Thöne-Reineke C; Steckelings UM; Unger T
    J Hypertens Suppl; 2006 Mar; 24(1):S115-21. PubMed ID: 16601564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond.
    Clermont A; Bursell SE; Feener EP
    J Hypertens Suppl; 2006 Mar; 24(1):S73-80. PubMed ID: 16601577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.